# Study Evaluating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 in Japanese Postmenopausal Women

> **NCT00826436** · — · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 16 (estimated)

## Conditions studied

- Uterine Leiomyomata (Fibroids)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00826436
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2009-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00826436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00826436, "Study Evaluating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 in Japanese Postmenopausal Women". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00826436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*